Sep 10 |
Zepbound And Mounjaro Maker Eli Illy Has A New CFO As It Navigates Regulatory Challenges: What You Should Know
|
Sep 10 |
Bernie Sanders Says If You're Poor In America You'll Live 10-15 Years Less: 'Anybody Else See A Problem With That?'
|
Sep 6 |
Biogen’s higher Spinraza dose shows better efficacy in Phase II/III trial
|
Sep 6 |
Pandemic Darling Moderna Needs a Reality Check
|
Sep 5 |
Amgen (AMGN) Up 5.8% Since Last Earnings Report: Can It Continue?
|
Sep 5 |
Biogen's Phase II/III SMA Study for Higher Spinraza Dose Meets Goals
|
Sep 4 |
Biogen Inc.'s (BIIB) Morgan Stanley's 22nd Annual Global Healthcare Conference Transcript
|
Sep 4 |
Biogen's Higher Dose Spinraza Shows To Slow Neurodegeneration Faster In Infants With Rare Neuromuscular Disorder
|
Sep 4 |
High-dose Spinraza meets study goal; Top Dyne executives exit
|
Sep 4 |
Biogen announces trial win for higher Spinraza doze
|